Literature DB >> 20571170

A study of TB-associated immune reconstitution inflammatory syndrome using the consensus case-definition.

Surendra K Sharma1, Sahajal Dhooria, Parag Barwad, Tamilarasu Kadhiravan, Sanjay Ranjan, Sunita Miglani, Deepak Gupta.   

Abstract

BACKGROUND &
OBJECTIVES: A considerable proportion of patients with HIV associated tuberculosis (TB) started on highly active antiretroviral therapy (HAART) develop immune reconstitution inflammatory syndrome (IRIS), which is difficult to diagnose in a resource-limited setting. In view of the recently proposed consensus case-definitions for TB-IRIS for use in resource-limited settings we undertook this study to describe the incidence and risk factors of TB associated IRIS in a tertiary care hospital and research centre in north India.
METHODS: Retrospective analysis of antiretroviral treatment (ART) naïve adults started on highly active ART (HAART) from June 2006 to September 2008 was done.
RESULTS: Of the 627 patients studied, 237 (38%) had TB at the initiation of HAART. In total, 18 (7.5%) of 237 patients with TB at baseline had paradoxical TB-associated IRIS, and 12 (3%) of 390 patients without TB at baseline developed ART-associated TB. Most IRIS events occurred during the initial 30 days of HAART. Two patients developed TB-associated IRIS after 90 days of HAART. Using univariate analysis, low CD4+ cell count at baseline [64 (28-89) vs. 95 (52-150); P=0.009] and early initiation of HAART [33 (24-41) vs. 48 (35-61) days; P<0.001] were significantly associated with paradoxical TB-associated IRIS. No identifiable risk factors were associated with the development of ART-associated TB. INTERPRETATION &amp;
CONCLUSION: A considerable proportion of patients on HAART develop TB-associated IRIS. The consensus case-definition is a useful tool in resource-limited settings for the diagnosis of TB- associated IRIS.

Entities:  

Mesh:

Year:  2010        PMID: 20571170

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  16 in total

1.  Integration of antiretroviral therapy with tuberculosis treatment.

Authors:  Salim S Abdool Karim; Kogieleum Naidoo; Anneke Grobler; Nesri Padayatchi; Cheryl Baxter; Andrew L Gray; Tanuja Gengiah; Santhanalakshmi Gengiah; Anushka Naidoo; Niraksha Jithoo; Gonasagrie Nair; Wafaa M El-Sadr; Gerald Friedland; Quarraisha Abdool Karim
Journal:  N Engl J Med       Date:  2011-10-20       Impact factor: 91.245

2.  Treatment paradox in musculo-skeletal tuberculosis in an immunocompetent adult male; a case report from a tertiary care hospital.

Authors:  Priyanka Chaskar; Geetika Rana; Nandini Duggal; Jyoti Arora
Journal:  J Clin Diagn Res       Date:  2015-04-01

3.  Worsening acute respiratory distress syndrome: Is it immune reconstitution inflammatory syndrome?

Authors:  Richa Saroa; Sanjeev Palta; Deepak Aggarwal; Satinder Gombar; Puja Saxena
Journal:  Indian J Crit Care Med       Date:  2013-11

Review 4.  Initiating antiretrovirals during tuberculosis treatment: a drug safety review.

Authors:  Tanuja N Gengiah; Andrew L Gray; Kogieleum Naidoo; Quarraisha Abdool Karim
Journal:  Expert Opin Drug Saf       Date:  2011-01-05       Impact factor: 4.250

5.  Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in children.

Authors:  Annelies Van Rie; Shobna Sawry; Ruth Link-Gelles; Shabir Madhi; Lee Fairlie; Charl Verwey; Nasreen Mahomed; David Murdoch; Harry Moultrie
Journal:  Pediatr Pulmonol       Date:  2015-06-14

Review 6.  Challenges in the diagnosis & treatment of miliary tuberculosis.

Authors:  Surendra K Sharma; Alladi Mohan; Abhishek Sharma
Journal:  Indian J Med Res       Date:  2012-05       Impact factor: 2.375

7.  Clinical characteristics of tuberculosis-associated immune reconstitution inflammatory syndrome in North Indian population of HIV/AIDS patients receiving HAART.

Authors:  Suman Karmakar; Surendra K Sharma; Richa Vashishtha; Abhishek Sharma; Sanjay Ranjan; Deepak Gupta; Vishnubhatla Sreenivas; Sanjeev Sinha; Ashutosh Biswas; Vinay Gulati
Journal:  Clin Dev Immunol       Date:  2010-12-01

Review 8.  HIV & immune reconstitution inflammatory syndrome (IRIS).

Authors:  Surendra K Sharma; Manish Soneja
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

Review 9.  Clinicopathological correlates in HIV seropositive tuberculosis cases presenting with jaundice after initiating antiretroviral therapy with a structured review of the literature.

Authors:  David A Barr; Pravistadevi K Ramdial
Journal:  BMC Infect Dis       Date:  2012-10-14       Impact factor: 3.090

10.  Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa.

Authors:  Lewis John Haddow; Mahomed-Yunus Suleman Moosa; Anisa Mosam; Pravi Moodley; Raveen Parboosing; Philippa Jane Easterbrook
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.